African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12512

Full Length Research Paper

Amino acyl tRNA synthetase inhibitors is therapeutics for gliomas at sub nanomolar concentrations

Peace C. Asuzu
  • Peace C. Asuzu
  • Feinberg School of Medicine, Northwestern University, Chicago Illinois, United States of America.
  • Google Scholar
Chidiebere U. Awah
  • Chidiebere U. Awah
  • Feinberg School of Medicine, Northwestern University, Chicago Illinois, United States of America.
  • Google Scholar


  •  Received: 30 September 2019
  •  Accepted: 19 December 2019
  •  Published: 31 January 2020

References

Anderson C, Schultz G (2003). Adaptation of an orthogonal archaeal leucyl-tRNA and synthetase pair for four-base, amber, and opal suppression. Biochemistry 42:9598-9608.
Crossref

 

Awah U, Li C, Mukesh B, Aayushi M, Jan W, Meeki L, Louisa W, Edgar G, Cheol P, Zhang D (2019). Interaction between DNA damage response, translation and apoptosome determines cancer susceptibility to TOP2 poison. BioRxiv. 
Crossref

 
 

Carter W, Wolfenden R (2015). tRNA acceptor stem and anticodon bases form independent codes related to protein folding. Proceedings of the National Academy of Sciences of the United States of America 112(24):7489-7494.
Crossref

 
 

Cavarelli J, Moras D (1993). Recognition of tRNAs by aminoacyl-tRNA synthetases. FASEB Journal 7:79-86.
Crossref

 
 

Cooperman JM, Rubin SH, Tabenkin B (1951). Effect of Niacin and Tryptophan in Counteracting Toxicity of Crystalline Borrelidin for Rat. Proceedings of the Society for Experimental Biology and Medicine 76:18-20.
Crossref

 
 

Fang P, Han H, Wang J, Chen K, Chen X, Guo M (2015). Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP Competitive Inhibitor. Chemistry & Biology 22(6):734-44.
Crossref

 
 

Habibi D, Ogloff N, Jalili RB, Yost A, Weng AP, Ghahary A, Ong CJ (2012). Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia. Investigational New Drugs 30(4):1361-70.
Crossref

 
 

Hancock SM, Uprety R, Deiters A, Chin, JW (2010). Expanding the genetic code of yeast for incorporation of diverse unnatural amino acids via a pyrrolysyl-tRNA synthetase/tRNA pair. Journal of the American Chemical Society 132(42):14819-14824.
Crossref

 
 

Jeong M, Kim H, Kim S, Park JH (2018). Liposomal borrelidin for treatment of metastatic breast cancer. Drug Delivery and Translational Research 8(5):1380-1388.
Crossref

 
 

Kim YW, Kwon C, Liu JL, Kim SH, Kim S (2012). Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma. PLoS One 7(8):e40960.
Crossref

 
 

Mehta A, Awah CU, Sonabend AM (2018). Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy. Frontiers in Neurology 9:459-463.
Crossref

 
 

Luque I, Riera-Alberola ML, Andújar A, Ochoa de Alda JA (2008). Intraphylum diversity and complex evolution of cyanobacterial aminoacyl-tRNA synthetases. Molecular Biology and Evolution 25(11):2369-89.
Crossref

 
 

Nagy A, Lánczky A, Menyhárt O, GyÅ‘rffy B (2018). Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.  Scientific Reports 8(1):9227.
Crossref

 
 

Normanly J, Kleina LG, Masson JM, Abelson J, Miller JH (1990). Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity. Journal of Molecular Biology 213(4):719-726.
Crossref

 
 

Ostrom QT, Cote D, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018). Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. JAMA Oncology 4(9):1254-1262.
Crossref

 
 

Sakamoto K, Hayashi A, Sakamoto A, Kiga D, Nakayama H, Soma A, Kobayashi T, Kitabatake M, Takio K, Saito K, Shirouzu M, Hirao I 2002). Site-specific incorporation of an unnatural amino acid into proteins in mammalian cells. Nucleic Acids Research 30(21):4692-4699.
Crossref

 
 

Sidhu A, Miller JR, Tripathi A, Garshott DM, Brownell AL, Chiego DJ, Arevang C, Zeng Q, Jackson LC, Bechler SA, Callaghan MU (2015). Borrelidin Induces the Unfolded Protein Response in Oral Cancer Cells and Chop-Dependent Apoptosis. ACS Medicinal Chemistry Letters 6(11):1122- 1127.
Crossref

 
 

Sugwara A, Tanaka T, Hirose T, Ishiyama A, Iwatsuki M, Takahashi Y, Otoguro K, ÅŒmura S, Sunazuka T (2013). Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against Plasmodium falciparum parasites. Bioorganic & Medicinal Chemistry Letters 23(8):2302-2305.
Crossref

 
 

Vellaichamy A, Sreekumar A, Strahler JR, Rajendiran T, Yu J, Varambally S, Li Y, Omenn GS, Chinnaiyan AM, Nesvizhskii AI (2009). Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases. PLoS One 4:e7075.
Crossref

 
 

Walter CW (2017). Coding of Class I and II aminoacyl-tRNA synthetases. Advances in Experimental Medicine and Biology 966:103-146.
Crossref

 
 

Wang L, Brock A, Herberich B, Schultz PG (2001). Expanding the genetic code of Escherichia coli. Science 292(5516):498-500.
Crossref

 
 

Winter J, Schwering M, Pelz O, Rauscher B, Zhan T, Heigwer F, Boutros M (2017). CRISPRAnalyzeR: Interactive analysis, annotation and documentation of pooled CRISPR screens. BioRxiv. 
Crossref

 
 

Zhang Z, Alfonta L, Tian F, Bursulaya B, Uryu S, King DS, Schultz PG (2004). Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 101(24):8882-8887.
Crossref